Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Conditions
Interventions
Intervention1: not applicable: not applicable
Control Intervention1: not applicable: not applicable
Sponsors
Afees Ahamed M A
ICMR grant if provided
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosed case of type 2 diabetes mellitus as per ADA guidelines Both inpatients and out patients of Kasturba Hospital, Manipal after obtaining consent
Exclusion criteria
Exclusion criteria: Acute diabetic complications â?? acutely ill Acute Coronary Syndrome within 1 year Hepatic dysfunction (Deranged LFT, USG - Cirrhosis) eGFR other causes of neuropathy â?? vitamin deficiency Use of any medication in the previous 1 month that might influence Uric acid levels (eg:Aspirin, allopurinol, levodopa, thiazide diuretics, furosemide, ethambutol,pyrazinamide, salicylate, niacin or cyclosporine, glucocorticoids, tacrolimus,Xylitol, testosterone)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To investigate the clinical relevance of uric acid levels to diabetic peripheral neuropathy. To know if measuring of uric acid levels can be indicative of diabetic peripheral neuropathyTimepoint: 2 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of peripheral neuropathy in type 2 diabetics visiting Kasturba Hospital, ManipalTimepoint: 2 years;To correlate HbA1c with uric acid levelsTimepoint: 2 years;To establish association between duration of diabetes with diabetic peripheral neuropathyTimepoint: 2 years | — |
Countries
India
Contacts
Public ContactDr Afees Ahamed M A
Kasturba Medical College, Manipal
Outcome results
None listed